Comparison of the gene expression profiles of CD44+ and CD24+ cells revealed that CD44+ cells specifically expressed multiple stem cell markers, which expression correlate with poor survival outcomes in breast cancer patients36. The gene discussed is CD44; the disease is breast cancer.